Sarah Hawley quoted by HealthDay about the exciting preliminary results of a breast cancer vaccine trial

You are here

Fri, May 08, 2015

The vaccine appears to slow spread in those with advanced breast cancer. Sarah Hawley was quoted, "The preliminary finding that the vaccine improved progression-free survival in patients with metastatic cancer [when the disease has spread to other parts of the body] is especially exciting because of the lack of good treatments for metastatic breast cancer... If the authors can replicate this result in future trials in metastatic and non-metastatic or newly diagnosed patients, this will represent an important direction for the field of breast cancer treatment research."